MintNeuro

MintNeuro is a pioneering semiconductor firm addressing a critical bottleneck in neurotechnology: the lack of advanced, fit-for-purpose chips for neural implants. The company develops miniaturized, low-power, and medically reliable integrated circuits that enable more minimally invasive and scalable devices for conditions like epilepsy, Parkinson's, and depression. By providing a modular chip platform for sensing, stimulation, and wireless communication, MintNeuro aims to accelerate the development of transformative neural interfaces, positioning itself as a key enabler rather than a therapeutic developer. Recent government awards and investment underscore its growing recognition in the advanced neurotech hardware space.

Purpose-built, ultra-low-power integrated circuit (IC) platform for neural implants. The modular chips support neural signal acquisition, on-chip processing, electrical stimulation, power management, and wireless communication, designed to medical-grade standards for miniaturization and safety.

MintNeuro operates in a niche but emerging segment of the semiconductor industry. Direct competitors may include other specialized IC design firms focusing on bioelectronics (e.g., Ripple Neuro, Blackrock Microsystems on the systems side, or custom ASIC designers). It also competes indirectly against internal development efforts by large medtech companies (e.g., Medtronic, Abbott) and the use of off-the-shelf general-purpose components. Its differentiation lies in its dedicated focus, medical design rigor, and modular platform approach.